OptimizeRx (NASDAQ:OPRX) versus ICTS International (OTCMKTS:ICTSF) Critical Comparison

ICTS International (OTCMKTS:ICTSF) and OptimizeRx (NASDAQ:OPRX) are both small-cap industrial products companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership.

Insider and Institutional Ownership

76.5% of OptimizeRx shares are owned by institutional investors. 62.4% of ICTS International shares are owned by insiders. Comparatively, 4.4% of OptimizeRx shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares ICTS International and OptimizeRx’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ICTS International	N/A	N/A	N/A
OptimizeRx	-24.56%	-7.72%	-6.65%

Earnings and Valuation

This table compares ICTS International and OptimizeRx’s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ICTS International	$324.98 million	0.58	-$4.72 million	N/A	N/A
OptimizeRx	$71.52 million	2.24	-$17.57 million	($1.01)	-8.71

ICTS International has higher revenue and earnings than OptimizeRx.

Analyst Ratings

This is a summary of current recommendations and price targets for ICTS International and OptimizeRx, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ICTS International	0	0	0	0	N/A
OptimizeRx	0	1	6	0	2.86

OptimizeRx has a consensus target price of $15.86, suggesting a potential upside of 80.19%. Given OptimizeRx’s higher possible upside, analysts clearly believe OptimizeRx is more favorable than ICTS International.

Risk & Volatility

ICTS International has a beta of 0.96, indicating that its share price is 4% less volatile than the S&P 500. Comparatively, OptimizeRx has a beta of 0.98, indicating that its share price is 2% less volatile than the S&P 500.

Summary

ICTS International beats OptimizeRx on 6 of the 11 factors compared between the two stocks.

About ICTS International

ICTS International N.V., together with its subsidiaries, provides airport security and other aviation services, and authentication technology services in the Netherlands, Germany, the United States, Spain, and internationally. The company offers security consulting and security handling services, including security screening, checkpoint screening, cargo screening, hold baggage screening, X-ray operator training, and integrated services, as well as passengers security screening and cargo security services; various aviation security training programs and seminars; and aviation security consulting services in the areas of risk analysis, System development, implementation and assimilation, and airport security surveys and audits; and explosive detection dog handling services. Its security and other services also comprise limited security services, including charter flight screening for airlines, cargo and aircraft security screening, catering security screening, and aircraft search to detect dangerous objects; and non-security services, such as agent services, guard services, queue monitors assisting passengers before the checkpoint, aircraft cleaning, janitorial, skycap passengers luggage, wheelchair attendant, baggage handling, cruise line baggage transfer, VIP meet and greet services, and equipment for passengers with restricted mobility, as well as shuttle services to airline crews. The company also develops and sells authentication security software to financial and other institutions; New Advanced Passenger Screening, an IT-system that enables pre-departure analysis of passenger information; X-Check including I-Check that supports the document screening process in high-risk flight environment; and authentication systems and solutions. ICTS International N.V. was founded in 1982 and is based in Schiphol, the Netherlands.

About OptimizeRx

OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers (HCPs), and patients. Its products and applications include Evidence-Based Physician Engagement solution to assist HCPs in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations; and Point of Care Banner messaging solution to deliver a variety of awareness and messaging within the clinical workflow. The company also offers Social Network Banner Messaging solution to deliver banner messaging to HCPs within their social network apps; Institutional Account-based Banner Messaging solution that provides its clients access to delivering banner messaging online and on the intranets of targeted health system accounts; and Financial Messaging solution, which provides prescribers visibility to branded copay offers and other patient support programs directly within their electronic health record and/or e-Prescribe systems. In addition, it provides Patient Engagement, a technology solution that provides digital messaging services through its cloud-based Mobile Health Messenger platform; HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance; and Therapy Initiation Workflow, a group of digital solutions that focuses on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was founded in 2006 and is headquartered in Rochester, Michigan.